Brief: NextCell Pharma Q4 EPS at SEK -0.25
26/10/2023 06:43
Oct 26 (Reuters) - NextCell Pharma Q4 EPS SEK -0.25. * Q4 operating income SEK 3.947 million
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln